Beyfortus

nirsevimab-alip

Approval

ApplicationBLA 761328
Approval dateJul 17, 2023
Approval year2023
SponsorAstrazeneca AB

FDA-approved use

To prevent respiratory syncytial virus (RSV) lower respiratory tract disease

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Beyfortus: